Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 5 Head and Neck Neoplasms 4 Esophageal Neoplasms 3 Nasopharyngeal Carcinoma 2 Esophageal Squamous Cell Carcinoma 2 Urinary Bladder Neoplasms 1 Recurrence 1 Pathologic Complete Response 1 Pancreatic cancer, adult 1 Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1

Interventions

Gemcitabine 3 surufatinib 1 nimotuzumab 1 S 1 (combination) 1 Oxaliplatin 1 Mass Screening 1 Leucovorin 1 Irinotecan 1 Hematologic Tests 1 Fluorouracil 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic cancer, adult × nimotuzumab × 1 year × Clear all

NCT07277452 2025-12-11

NOTABLE-309

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic cancer, adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡